Policy ID: 8bd068a4-0160-4bdc-8725-2b8b9b4a8643
Version: 4.6
Created At: 2025-12-06T23:05:13.436734+00:00
Last Updated: 2025-12-06T23:05:13.436734+00:00
Title: Internal Medicine Medication Management Policy
Specialty: Internal Medicine
Policy Type: medication-management
Complexity: simple
Approval Status: draft
Evidence Level: Level II - Randomized Controlled Trial
Review Frequency: Annually
Effective Date: 2025-12-06T23:05:13.436734+00:00
Next Review Date: 2026-12-31T00:00:00+00:00

AUTHOR:
Name: Dr. Johnson Taylor
Title: Clinical Director
Department: Internal Medicine Department
Email: clinical.director@hospital-624.example.com

APPROVERS:
- Name: Dr. Garcia Robinson | Title: Chief Medical Officer | Department: Medical Executive Committee | Approved At: 2025-12-06T23:05:13.436734+00:00

PURPOSE:
To provide evidence-based guidance for medication management in Internal Medicine practice to ensure optimal patient outcomes and standardized care delivery.

SCOPE:
Patient Populations:
- Adult patients presenting with internal medicine conditions
- Patients requiring medication management intervention

Clinical Settings:
- Emergency Department
- Inpatient Ward
- Outpatient Clinic

Exclusion Criteria:
- Pediatric patients under 18 years
- Patients with multiple comorbidities requiring specialized care

BACKGROUND:
Clinical Rationale: Current evidence supports standardized approaches to medication management in Internal Medicine to improve patient safety and clinical outcomes.
Epidemiology: Approximately 47% of internal medicine cases require this type of intervention annually.
Current Evidence Summary: Multiple Level II studies demonstrate efficacy of standardized protocols in reducing adverse events and improving patient satisfaction.

CARE PATHWAY:

Phase 1: Initial Assessment (Within 30 minutes of presentation)
Description: Comprehensive patient evaluation and risk stratification

Phase 2: Treatment Planning (Within 2 hours of initial assessment)
Description: Development of individualized treatment approach
